Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

13.76
Delayed Data
As of 3:59pm ET
 +0.09 / +0.66%
Today’s Change
5.70
Today|||52-Week Range
19.00
+26.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.0013.0M15.8M
 
 
 
Depreciation And Amortization51.0K61.0K410.0K582.0K
 
 
 
 
 
 
Operating ExpensesGross Income-51.0K-61.0K12.6M15.2M
 
 
 
 
 
General Expenses18.7M25.1M23.1M37.0M
 
 
 
 
 
Other Operating Expenses935.0K0.000.000.00
 
 
Research And Development13.5M18.4M15.9M17.0M
 
 
 
 
 
Total Operating Expenses19.7M25.2M23.5M37.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.7M-25.2M-10.5M-21.8M
 
 
 
 
 
Extraordinary Charge0.000.00-348.0K0.00
 
 
Interest Expense On Debt7.0K19.0K150.0K186.0K
 
 
 
 
 
Equity In Earnings0.000.000.00-302.0K
 
 
Other Expenses-31.0K-142.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.4M-24.5M-10.9M-21.5M
 
 
 
 
 
Income Taxes-51.0K-73.0K-1.0K0.00
 
 
 
 
Net Income-19.4M-24.6M-10.9M-21.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.1M3.9M3.1M10.1M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M3.9M3.1M10.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.30-$6.23-$3.53-$2.16
 
 
 
 
 
EPS Diluted-$6.30-$6.23-$3.53-$2.16